Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hossam Nada

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of an Achiral Small Molecule TREM2 Agonist with Improved Pharmacokinetic Profile and Validated Target EngagementShaoren Yuan, Farida El Gaamouch, Sungwoo Cho, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
As48, a First-in-Class Dual-Function TREM2 Modulator: Receptor Activation and Shedding InhibitionSungwoo Cho, Farida El Gaamouch, Saurabh Upadhyay, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Discovery of a Small Molecule TREM2 Agonist with Improved In Vitro Pharmacokinetic Profile and Validated Target EngagementShaoren Yuan, Farida El Gaamouch, Sungwoo Cho, et al.
Signal Transduction and Targeted Therapy|December 5, 2024
New insights into protein-protein interaction modulators in drug discovery and therapeutic advanceHossam Nada, Yongseok Choi, Sungdo Kim, et al.
Journal of Medicinal Chemistry|August 20, 2025
Discovery and Optimization of LAG-3-Targeted Small Molecules via DNA-Encoded Chemical Library (DEL) Screening for Cancer ImmunotherapySomaya A Abdel-Rahman, Laura Calvo-Barreiro, Nelson García Vázquez, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
TREM2 Activation by First-in-Class Direct Small Molecule Agonists: DEL Screening, Optimization, Biophysical Validation, and Functional CharacterizationHossam Nada, Farida El Gaamouch, Sungwoo Cho, et al.
Biomedicines|September 28, 2021
Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor ActivityMohamed H Elsherbeny, Ahmed Elkamhawy, Hossam Nada, et al.
Computer Methods and Programs in Biomedicine|July 11, 2024
From pixels to druggable leads: A CADD strategy for the design and synthesis of potent DDR1 inhibitorsHossam Nada, Sungdo Kim, Cho Jaemin, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
HTS-Oracle: A Retrainable AI Platform for High-Confidence Hit Identification Across Difficult-to-Drug TargetsHossam Nada, Laura Calvo-Barreiro, Sungwoo Cho, et al.
Medicinal Research Reviews|February 2, 2024
Natural products as IL-6 inhibitors for inflammatory diseases: Synthetic and SAR perspectiveDipesh S Harmalkar, Aneesh Sivaraman, Hossam Nada, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|July 16, 2025
Discovery of an Achiral Small Molecule TREM2 Agonist with Improved Pharmacokinetic Profile and Validated Target EngagementShaoren Yuan, Farida El Gaamouch, Sungwoo Cho, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
As48, a First-in-Class Dual-Function TREM2 Modulator: Receptor Activation and Shedding InhibitionSungwoo Cho, Farida El Gaamouch, Saurabh Upadhyay, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Discovery of a Small Molecule TREM2 Agonist with Improved In Vitro Pharmacokinetic Profile and Validated Target EngagementShaoren Yuan, Farida El Gaamouch, Sungwoo Cho, et al.
Signal Transduction and Targeted Therapy|December 5, 2024
New insights into protein-protein interaction modulators in drug discovery and therapeutic advanceHossam Nada, Yongseok Choi, Sungdo Kim, et al.
Journal of Medicinal Chemistry|August 20, 2025
Discovery and Optimization of LAG-3-Targeted Small Molecules via DNA-Encoded Chemical Library (DEL) Screening for Cancer ImmunotherapySomaya A Abdel-Rahman, Laura Calvo-Barreiro, Nelson García Vázquez, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
TREM2 Activation by First-in-Class Direct Small Molecule Agonists: DEL Screening, Optimization, Biophysical Validation, and Functional CharacterizationHossam Nada, Farida El Gaamouch, Sungwoo Cho, et al.
Biomedicines|September 28, 2021
Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor ActivityMohamed H Elsherbeny, Ahmed Elkamhawy, Hossam Nada, et al.
Computer Methods and Programs in Biomedicine|July 11, 2024
From pixels to druggable leads: A CADD strategy for the design and synthesis of potent DDR1 inhibitorsHossam Nada, Sungdo Kim, Cho Jaemin, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
HTS-Oracle: A Retrainable AI Platform for High-Confidence Hit Identification Across Difficult-to-Drug TargetsHossam Nada, Laura Calvo-Barreiro, Sungwoo Cho, et al.
Medicinal Research Reviews|February 2, 2024
Natural products as IL-6 inhibitors for inflammatory diseases: Synthetic and SAR perspectiveDipesh S Harmalkar, Aneesh Sivaraman, Hossam Nada, et al.
Pageof 8